Stock Watch: The Deal Flow Before Christmas
A Last-Minute Blizzard Of Transactions Boosted Biotech
A bumper December of licensing transactions and acquisitions involving biotech companies brought the feelgood factor back to the sector. But while big spending in the run-up to Christmas may not dent pharma’s credit cards, it might crimp its investors’ dividends.
